South Africa Women's Health Market Size & Outlook

The women's health market in South Africa is expected to reach a projected revenue of US$ 330.8 million by 2030. A compound annual growth rate of 5.9% is expected of South Africa women's health market from 2025 to 2030.
Revenue, 2024 (US$M)
$226.8
Forecast, 2030 (US$M)
$330.8
CAGR, 2025 - 2030
5.9%
Report Coverage
South Africa

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa women's health market, 2018-2030 (US$M)

South Africa women's health market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

South Africa women's health market highlights

  • The South Africa women's health market generated a revenue of USD 226.8 million in 2024 and is expected to reach USD 330.8 million by 2030.
  • The South Africa market is expected to grow at a CAGR of 5.9% from 2025 to 2030.
  • In terms of segment, contraceptives was the largest revenue generating application in 2024.
  • Hormonal Infertility is the most lucrative application segment registering the fastest growth during the forecast period.


Women's health market data book summary

Market revenue in 2024USD 226.8 million
Market revenue in 2030USD 330.8 million
Growth rate5.9% (CAGR from 2025 to 2030)
Largest segmentContraceptives
Fastest growing segmentHormonal Infertility
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationPostmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Hormonal Infertility, Contraceptives, Menopause, Polycystic Ovary Syndrome (PCOS)
Key market players worldwideAbbVie Inc, Bayer AG, Merck & Co Inc, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Agile Therapeutics Inc, Amgen Inc, Apothecus, Blairex Laboratories, Ferring


Other key industry trends

  • In terms of revenue, South Africa accounted for 0.5% of the global women's health market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, Saudi Arabia women's health market is projected to lead the regional market in terms of revenue in 2030.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 330.8 million by 2030.

Contraceptives was the largest segment with a revenue share of 38.93% in 2024. Horizon Databook has segmented the South Africa women's health market based on postmenopausal osteoporosis, endometriosis & uterine fibroids, hormonal infertility, contraceptives, menopause, polycystic ovary syndrome (pcos) covering the revenue growth of each sub-segment from 2018 to 2030.


In Africa, approximately 22.6% of women of reproductive age do not have access to advanced contraceptives. Hence, women's health products have not yet penetrated South Africa, but the market is expected to grow at a substantial rate over the forecast period.

Some of the key factors anticipated to result in market growth are high unmet medical needs, increasing awareness about women's health issues, and the growing population of elderly women. Anemia affects approximately one-third of women in South Africa.

Such a high prevalence of anemia is increasing the risk of developing severe women’s health issues in the country. Moreover, according to the International Osteoporosis Foundation, about 1.4 million women aged above 50 are suffering from osteoporosis.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Women's Health Market Companies

Name Profile # Employees HQ Website
Apothecus View profile 11-50 Hicksville, New York, United States, North America https://apothecus.com
Blairex Laboratories View profile 101-250 Columbus, Indiana, United States, North America http://www.blairex.com
Agile Therapeutics Inc View profile 19 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 https://www.agiletherapeutics.com
Ferring View profile 5001-10000 Saint-prex, Vaud, Switzerland, Europe https://www.ferring.com
Bayer AG View profile 99723 Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 https://www.bayer.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Amgen Inc View profile 26700 One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 https://www.amgen.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com

South Africa Application - Women's Health Market size, 2024 - 2030 (US$M)

South Africa Women's Health Market Outlook Share, 2024 & 2030 (US$M)

South Africa Application - Women's Health Market size, 2024 - 2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online